Assessment of anti-inflammatory cytokines in professional lung diseases Source: Eur Respir J 2005; 26: Suppl. 49, 148s Year: 2005
Role of anti-inflammatory treatments in complex chronic comorbidities Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases Year: 2006
The effectiveness of N-acetylcysteine in the suppression of pro-inflammatory cytokines in patients with COPD Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease Year: 2021
An update on anti-inflammatory endogenous mediators Source: Annual Congress 2005 - Mechanisms of resolution of inflammation Year: 2005
Dynamic of proinflammatory cytokines system and nonspecific markers of inflammation in patients with COPD before and after treatment with broncholitics Source: Eur Respir J 2006; 28: Suppl. 50, 38s Year: 2006
The role anti-inflammatory cytokines in pathogenesis professional occupetional pulmonary disease Source: Eur Respir J 2003; 22: Suppl. 45, 122s Year: 2003
Macrolide effects on the prevention of COPD exacerbations Source: Eur Respir J 2012; 40: 485-494 Year: 2012
Rosuvastatin influence on inflammatory and anti-inflammatory cytokines in blood in patients with chronic obstructive pulmonary disease Source: International Congress 2017 – COPD management Year: 2017
Leptin and inflammatory cytokines during COPD exacerbation Source: Eur Respir J 2002; 20: Suppl. 38, 252s Year: 2002
The role of proinflammatory cytokines in severe COPD patients before and after roflumilast treatment Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016
The proinflammatory cytokine is important in determining the severity of asthma enhancing the inflammatory process Source: Eur Respir J 2004; 24: Suppl. 48, 592s Year: 2004
The level of anti-inflammatory cytokine IL-10 in patients with chronic obstructive pulmonary disease of varying severity Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013
Influence of proinflammatory cytokines on osteopenia development in sarcoidosis Source: Eur Respir J 2006; 28: Suppl. 50, 540s Year: 2006
Cytokine regulation of local and systemic inflammation in COPD patients Source: Annual Congress 2010 - Novel markers of lung injury Year: 2010
Pro- and anti-inflammatory cytokines TNF-alpha, IFN-gamma, IL-10 and TGF-beta1 levels in blood serum as markers of plasmaferesis success and inflammation activity in lung sarcoidosis (LS) Source: Eur Respir J 2006; 28: Suppl. 50, 676s Year: 2006
Effect of aerosolized antibiotics on proinflammatory cytokines Source: Eur Respir J 2002; 20: Suppl. 38, 526s Year: 2002
Pro-inflammatory / anti-inflammatory capacity of lymphocyte cells in COPD Source: International Congress 2019 – Immunopathological mechanisms of lung disease Year: 2019
IL-10 and IL-1ra mediates OVA-induced Th2 airway allergic response at short and long-term Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury Year: 2013
Effects of dexamethasone and anti-inflammatory drugs on inflammatory cytokines from bronchial epithelial cells of COPD patients Source: International Congress 2015 – New insights into lung disease pathogenesis Year: 2015